Moderna Announces Successful Trial of Combined Covid and Flu Vaccine, Seeks Regulatory Approval

Monday, 10 June 2024, 10:30
In a significant development, Moderna has achieved success in combined Covid and flu vaccine trials and is now in the process of seeking regulatory approval for the innovative jab. This move demonstrates Moderna's commitment to diversifying its product portfolio and addressing multiple health challenges with a single solution. The successful trial results mark a major milestone for the company and the healthcare industry, showcasing the potential for effective dual-protection against Covid-19 and influenza.
LivaRava Finance Meta Image
Moderna Announces Successful Trial of Combined Covid and Flu Vaccine, Seeks Regulatory Approval

Moderna Reports Positive Trial Results

In a significant development, Moderna has achieved success in combined Covid and flu vaccine trials.

Regulatory Approval Sought

The company is now in the process of seeking regulatory approval for the innovative jab.

This move demonstrates Moderna's commitment to diversifying its product portfolio and addressing multiple health challenges with a single solution.

The successful trial results mark a major milestone for the company and the healthcare industry, showcasing the potential for effective dual-protection against Covid-19 and influenza.

Do you want to advertise here? Contact us
Do you want to advertise here? Contact us
Newsletter

We carefully select news from the world of finance and publish it for our users. We understand the importance of reliable and up-to-date information for people in the financial world. Do you want to receive news in a convenient format and always have it at hand — subscribe to our newsletter and make your analytical work more effective.

Subscribe